Medicare AdvantageJune 20, 2024
Anthem expands specialty pharmacy precertification list
Effective for dates of service on and after October 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.
Federal and state law, as well as state contract language and CMS guidelines (including definitions and specific contract provisions/exclusions), take precedence over these precertification rules. They must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.
HCPCS codes | Medicare Part B drugs |
J3490, J3590 | Amtagvi (lifleucel) |
J3490, J3590 | iDoseTR (travoprost implant) |
Medicare services provided by Anthem Blue Cross and Blue Shield, trade name of Anthem HealthChoice HMO, Inc. and Anthem HealthChoice Assurance, Inc., Anthem Blue Cross and Blue Shield HP, trade name of Anthem HP, LLC., or Anthem Blue Cross and Blue Shield Retiree Solutions, trade name of Anthem Insurance Companies, Inc.
Independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
MULTI-BCBS-CR-058746-24-CPN58434
PUBLICATIONS: July 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone